Jump to content

Nucleoside

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Daiyusha (talk | contribs) at 05:54, 4 October 2021 (Reverting edit(s) by 172.249.59.156 (talk) to rev. 1048087899 by ClueBot NG: non-constructive (RW 16.1)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

deoxyadenosine
deoxyadenosine
adenosine
adenosine
Two corresponding nucleosides, the deoxyribonucleoside, deoxyadenosine, and the ribonucleoside, adenosine. Both are in line-angle representation, where the presence of carbon atoms are inferred at each angle, as are the hydrogen atoms attached to the carbon, to fill its valency (to having four bonds).

Nucleosides are glycosylamines that can be thought of as nucleotides without a phosphate group. A nucleoside consists simply of a nucleobase (also termed a nitrogenous base) and a five-carbon sugar (ribose or 2'-deoxyribose) whereas a nucleotide is composed of a nucleobase, a five-carbon sugar, and one or more phosphate groups. In a nucleoside, the anomeric carbon is linked through a glycosidic bond to the N9 of a purine or the N1 of a pyrimidine. Nucleotides are the molecular building-blocks of DNA and RNA.

List of nucleosides and corresponding nucleobases

The reason for 2 symbols, shorter and longer, is that the shorter ones are better for contexts where explicit disambiguation is superfluous (because context disambiguates) and the longer ones are for contexts where explicit disambiguation is judged to be needed or wise. For example, when discussing long nucleobase sequences in genomes, the CATG symbol system is much preferable to the Cyt-Ade-Thy-Gua symbol system (see Nucleic acid sequence § Notation for examples), but in discussions where confusion is likelier, the unambiguous symbols can be used.

Nitrogenous base Ribonucleoside Deoxyribonucleoside
Chemical structure of adenine
adenine
symbol A or Ade
Chemical structure of adenosine
adenosine
symbol A or Ado
Chemical structure of deoxyadenosine
deoxyadenosine
symbol dA or dAdo
Chemical structure of guanine
guanine
symbol G or Gua
Chemical structure of guanosine
guanosine
symbol G or Guo
Chemical structure of deoxyguanosine
deoxyguanosine
symbol dG or dGuo
Chemical structure of thymine
thymine
(5-methyluracil)
symbol T or Thy
Chemical structure of 5-methyluridine
5-methyluridine
(ribothymidine)
symbol m⁵U
Chemical structure of thymidine
thymidine
(deoxythymidine)
symbol dT or dThd
(dated: T or Thd)
Chemical structure of uracil
uracil
symbol U or Ura
Chemical structure of uridine
uridine
symbol U or Urd
Chemical structure of deoxyuridine
deoxyuridine
symbol dU or dUrd
Chemical structure of cytosine
cytosine
symbol C or Cyt
Chemical structure of cytidine
cytidine
symbol C or Cyd
Chemical structure of deoxycytidine
deoxycytidine
symbol dC or dCyd

Sources

Nucleosides can be produced from nucleotides de novo, particularly in the liver, but they are more abundantly supplied via ingestion and digestion of nucleic acids in the diet, whereby nucleotidases break down nucleotides (such as the thymidine monophosphate) into nucleosides (such as thymidine) and phosphate. The nucleosides, in turn, are subsequently broken down in the lumen of the digestive system by nucleosidases into nucleobases and ribose or deoxyribose. In addition, nucleotides can be broken down inside the cell into nitrogenous bases, and ribose-1-phosphate or deoxyribose-1-phosphate.

Use in medicine and technology

In medicine several nucleoside analogues are used as antiviral or anticancer agents.[1][2][3][4] The viral polymerase incorporates these compounds with non-canonical bases. These compounds are activated in the cells by being converted into nucleotides. They are administered as nucleosides since charged nucleotides cannot easily cross cell membranes.

In molecular biology, several analogues of the sugar backbone exist. Due to the low stability of RNA, which is prone to hydrolysis, several more stable alternative nucleoside/nucleotide analogues that correctly bind to RNA are used. This is achieved by using a different backbone sugar. These analogues include locked nucleic acids (LNA), morpholinos and peptide nucleic acids (PNA).

In sequencing, dideoxynucleotides are used. These nucleotides possess the non-canonical sugar dideoxyribose, which lacks 3' hydroxyl group (which accepts the phosphate). It therefore cannot bond with the next base and terminates the chain, as DNA polymerases cannot distinguish between it and a regular deoxyribonucleotide.

Prebiotic synthesis of ribonucleosides

In order to understand how life arose, knowledge is required of the chemical pathways that permit formation of the key building blocks of life under plausible prebiotic conditions. According to the RNA world hypothesis free-floating ribonucleosides and ribonucleotides were present in the primitive soup. Molecules as complex as RNA must have arisen from small molecules whose reactivity was governed by physico-chemical processes. RNA is composed of purine and pyrimidine nucleotides, both of which are necessary for reliable information transfer, and thus Darwinian natural selection and evolution. Nam et al.[5] demonstrated the direct condensation of nucleobases with ribose to give ribonucleosides in aqueous microdroplets, a key step leading to RNA formation. Also, a plausible prebiotic process for synthesizing pyrimidine and purine ribonucleosides and ribonucleotides using wet-dry cycles was presented by Becker et al. [6]

See also

References

  1. ^ Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan, Tharanikkarasu (December 2020). "Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders". European Journal of Medicinal Chemistry. 207: 112801. doi:10.1016/j.ejmech.2020.112801. PMID 32927231. S2CID 221724578.
  2. ^ Galmarini, Carlos M.; MacKey, John R.; Dumontet, Charles (2002). "Nucleoside analogues and nucleobases in cancer treatment". The Lancet Oncology. 3 (7): 415–424. doi:10.1016/S1470-2045(02)00788-X. PMID 12142171.
  3. ^ Jordheim, Lars Petter; Durantel, David; Zoulim, Fabien; Dumontet, Charles (2013). "Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases". Nature Reviews Drug Discovery. 12 (6): 447–464. doi:10.1038/nrd4010. PMID 23722347. S2CID 39842610.
  4. ^ Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan, Tharanikkarasu (12 February 2021). "Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections". ChemMedChem. 16 (9): 1403–1419. doi:10.1002/cmdc.202000849. PMID 33427377. S2CID 231576801. Retrieved 13 March 2021.
  5. ^ Nam I, Nam HG, Zare RN. Abiotic synthesis of purine and pyrimidine ribonucleosides in aqueous microdroplets. Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):36-40. doi: 10.1073/pnas.1718559115. Epub 2017 Dec 18. PMID: 29255025; PMCID: PMC5776833
  6. ^ Becker S, Feldmann J, Wiedemann S, Okamura H, Schneider C, Iwan K, Crisp A, Rossa M, Amatov T, Carell T. Unified prebiotically plausible synthesis of pyrimidine and purine RNA ribonucleotides. Science. 2019 Oct 4;366(6461):76-82. doi: 10.1126/science.aax2747. PMID: 31604305.